2.77Open2.77Pre Close0 Volume1 Open Interest5.00Strike Price0.00Turnover365.61%IV-19.89%PremiumJul 19, 2024Expiry Date3.14Intrinsic Value100Multiplier12DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.8655Delta0.1738Gamma0.58Leverage Ratio-0.0100Theta-0.0012Rho-0.50Eff Leverage0.0008Vega
Standard BioTools Stock Discussion
assay services, kits and related revenue in 2024; and
-- Ended the quarter with cash, cash equivalents, restricted cash and
short-term investments of $464 million, after accounting for $71 million
cash payments for merger-related expenses, settlement of year-end
operating accruals, debt retirement and completed stock buybacks.
2 MINUTES AGO, 8:00 AM EDT
VIA GLOBENEWSWIRE
Benzinga· 1 min ago
No comment yet